Breaking News Instant updates and real-time market news.

PCG

PG&E

$12.70 /

+0.295 (+2.38%)

 16:52
09/28/22
 09/28
16:52
 09/28/22
16:52

PG&E seeks CPUC approval to sell stake in power plants

According to a regulatory filing, on September 28, 2022, Pacific Gas and Electric Company, a subsidiary of PG&E Corporation, filed an application with the California Public Utilities Commission regarding the separation of its non-nuclear generation assets into a stand-alone Utility subsidiary and the potential sale of a minority ownership stake in the newly-formed subsidiary to one or more investors to be identified. PG&E Corporation made available a presentation regarding the Application. In addition, PG&E Corporation is reaffirming its previously announced non-GAAP core earnings guidance for fiscal year 2022.

  • 13

    Nov

  • 01

    Feb

OTHER BREAKING NEWS FROM THE FLY

Recommendations
iClick Interactive Asia price target lowered to $3.50 from $17 at Citi » 06:45
12/06/22
12/06
06:45
12/06/22
06:45
ICLK

iClick Interactive Asia

$2.75 /

+0.05 (+1.85%)

Citi analyst Nelson…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ICLK iClick Interactive Asia
$2.75 /

+0.05 (+1.85%)

11/30/22
iClick Interactive Asia regains compliance with Nasdaq listing rules
10/31/22
iClick Interactive Asia implements ADS ratio change
06/27/22
iClick Interactive Asia releases metaverse livestreaming mobile app Arohar
06/15/22
iClick Interactive Asia receives minimum bid price notice from Nasdaq
ICLK iClick Interactive Asia
$2.75 /

+0.05 (+1.85%)

08/25/22 Benchmark
iClick Interactive Asia downgraded to Hold from Buy at Benchmark
05/31/22 Benchmark
iClick Interactive Asia price target lowered to $2 from $8 at Benchmark
03/24/22 Benchmark
iClick Interactive Asia price target lowered to $8 from $12 at Benchmark
03/24/22 Alliance Global Partners
Alliance Global downgrades iClick Interactive Asia pending greater clarity
ICLK iClick Interactive Asia
$2.75 /

+0.05 (+1.85%)

11/30/22
iClick Interactive Asia reports Q3 EPS (10c), consensus ($1.34)
08/25/22
iClick Interactive Asia reports Q2 adjusted EPS (15c), consensus (6c)
ICLK iClick Interactive Asia
$2.75 /

+0.05 (+1.85%)

08/26/22
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
Recommendations
Comerica price target lowered to $80 from $90 at Citi » 06:43
12/06/22
12/06
06:43
12/06/22
06:43
CMA

Comerica

$66.51 /

-3.65 (-5.20%)

Citi analyst Keith…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CMA Comerica
$66.51 /

-3.65 (-5.20%)

08/30/22
Comerica appoints Von Hays as EVP, CLO, general counsel
08/29/22
Comerica appoints Kelly Gage as director of investor relations
07/20/22
Comerica rises 5.0%
06/13/22
Comerica to consolidate 22 of existing 432 U.S. bank locations
CMA Comerica
$66.51 /

-3.65 (-5.20%)

12/05/22 Morgan Stanley
Comerica initiated with an Equal Weight at Morgan Stanley
12/01/22 Wolfe Research
Comerica price target raised to $80 from $79 at Wolfe Research
11/21/22 Raymond James
Comerica upgraded to Outperform from Market Perform at Raymond James
11/21/22 Raymond James
Comerica upgraded to Outperform from Market Perform at Raymond James
CMA Comerica
$66.51 /

-3.65 (-5.20%)

10/19/22
Comerica reports Q3 EPS $2.60, consensus $2.57
07/20/22
Comerica reports Q2 EPS $1.37, consensus $1.78
CMA Comerica
$66.51 /

-3.65 (-5.20%)

10/19/22
Fly Intel: Pre-market Movers
01/19/23
Comerica - CMA
CMA Comerica
$66.51 /

-3.65 (-5.20%)

06/13/22
Early notable gainers among liquid option names on June 13th
Upgrade
Zoomlion upgraded to Buy from Hold at HSBC » 06:43
12/06/22
12/06
06:43
12/06/22
06:43
ZLIOY

Zoomlion

$4.65 /

+ (+0.00%)

HSBC analyst Helen Fang…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Downgrade
New Gold downgraded to Reduce from Hold at TD Securities » 06:42
12/06/22
12/06
06:42
12/06/22
06:42
NGD

New Gold

$1.15 /

-0.09 (-7.29%)

TD Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NGD New Gold
$1.15 /

-0.09 (-7.29%)

10/12/22
New Gold reports Q3 gold equivalent output 91,021 ounces vs 105,628 last year
09/29/22
Cenovus to help advance sustainable energy opportunities for First Nations
09/07/22
New Gold provides drill results from program at New Afton Mine
07/11/22
New Gold cuts FY22 gold equivalent production view to 325,000-365,000 ounces
NGD New Gold
$1.15 /

-0.09 (-7.29%)

10/14/22 National Bank
New Gold price target raised to C$1.60 from C$1.50 at National Bank
10/13/22 National Bank
New Gold price target raised to C$1.50 from C$1.40 at National Bank
10/03/22 National Bank
New Gold price target raised to C$1.40 from C$1.20 at National Bank
10/03/22 RBC Capital
New Gold upgraded to Outperform from Sector Perform at RBC Capital
NGD New Gold
$1.15 /

-0.09 (-7.29%)

11/30/22
Largest borrow rate increases among liquid names
Hot Stocks
Meta threatens to pull news from platform if Congress passes journalism bill » 06:41
12/06/22
12/06
06:41
12/06/22
06:41
META

Meta Platforms

$122.47 /

-1.015 (-0.82%)

In a Monday tweet, Andy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
META Meta Platforms
$122.47 /

-1.015 (-0.82%)

12/05/22
Meta expands age verification test to Facebook Dating in U.S.
12/05/22
User reports indicate problems at Meta's Facebook, Downdetector says
11/28/22
Meta fined EUR265M over Facebook data leak involving more than 533M users
11/23/22
German regulator says Meta to allow VR headset without a Facebook account
META Meta Platforms
$122.47 /

-1.015 (-0.82%)

11/15/22 Morgan Stanley
Meta Platforms price target lowered to $100 from $105 at Morgan Stanley
11/10/22 Canaccord
Meta Platforms price target lowered to $170 from $200 at Canaccord
11/09/22 Itau BBA
Meta Platforms price target raised to $120 from $102 at Itau BBA
11/09/22 Baird
Meta layoffs represent 'significant shift in strategy,' says Baird
META Meta Platforms
$122.47 /

-1.015 (-0.82%)

11/09/22
Meta Platforms backs Q4 revenue outlook $30B-$32.5B, consensus $31.52B
10/26/22
Meta Platforms sees Q4 revenue $30B-$32.5B, consensus $32.31B
10/26/22
Meta Platforms reports Q3 EPS $1.64, consensus $1.89
10/26/22
Notable companies reporting after market close
META Meta Platforms
$122.47 /

-1.015 (-0.82%)

12/01/22
Meta attempted to settle E.U. antitrust investigations, Reuters reports
12/01/22
Zuckerberg says Apple's app policies 'not sustainable,' Axios reports
11/30/22
Meta giving up some offices at Manhattan's Hudson Yards, Bloomberg reports
11/22/22
H&R Block, TaxAct sending users' information to Facebook, The Markup reports
META Meta Platforms
$122.47 /

-1.015 (-0.82%)

12/01/22
What You Missed On Wall Street On Thursday
12/01/22
What You Missed On Wall Street This Morning
11/30/22
#SocialStocks: Twitter and Apple spar over advertising, censorship
11/23/22
#SocialStocks: TikTok data transfers under investigation in EU
META Meta Platforms
$122.47 /

-1.015 (-0.82%)

12/02/22
Notable open interest changes for December 2nd
11/09/22
Early notable gainers among liquid option names on November 9th
11/09/22
Unusually active option classes on open November 9th
11/07/22
Early notable gainers among liquid option names on November 7th
Initiation
Norwegian Cruise Line assumed with an Overweight at JPMorgan » 06:40
12/06/22
12/06
06:40
12/06/22
06:40
NCLH

Norwegian Cruise Line

$16.22 /

-0.325 (-1.96%)

JPMorgan analyst Daniel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NCLH Norwegian Cruise Line
$16.22 /

-0.325 (-1.96%)

11/28/22
OneSpaWorld enters seven-year contract with Norwegian Cruise Line
11/16/22
Norwegian Cruise Line CEO sells $1.06M in common stock
11/08/22
Norwegian Cruise Line expects to report net loss for Q4
11/08/22
Norwegian Cruise Line on track to generate positive adjusted FCF in Q4
NCLH Norwegian Cruise Line
$16.22 /

-0.325 (-1.96%)

06:35 Today JPMorgan
Royal Caribbean assumed with Underweight from Overweight at JPMorgan
11/22/22 Truist
Norwegian Cruise Line price target raised to $21 from $19 at Truist
11/17/22 Credit Suisse
Norwegian Cruise downgraded to Underperform from Outperform at Credit Suisse
11/14/22 UBS
Norwegian Cruise Line price target raised to $24 from $15 at UBS
NCLH Norwegian Cruise Line
$16.22 /

-0.325 (-1.96%)

11/08/22
Norwegian Cruise Line sees Q4 reveue $1.4B-$1.5B, consensus $1.46B
11/08/22
Norwegian Cruise Line reports Q3 adjusted EPS (64c), consensus (70c)
08/09/22
Norwegian Cruise Line sees Q3 revenue $1.5B-$1.6B, consensus $1.88B
08/09/22
Norwegian Cruise Line reports Q2 adjusted EPS ($1.14), consensus (86c)
NCLH Norwegian Cruise Line
$16.22 /

-0.325 (-1.96%)

07/02/22
Not the time to bottom-fish cruise operator stocks, Barron's says
NCLH Norwegian Cruise Line
$16.22 /

-0.325 (-1.96%)

11/19/22
Buy/Sell: Wall Street's top 10 stock calls this week
11/17/22
What You Missed On Wall Street On Thursday
11/17/22
What You Missed On Wall Street This Morning
11/17/22
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
12/12/22
Norwegian Cruise Line
12/13/22
Norwegian Cruise Line
NCLH Norwegian Cruise Line
$16.22 /

-0.325 (-1.96%)

12/05/22
Early notable gainers among liquid option names on December 5th
11/08/22
Early notable gainers among liquid option names on November 8th
11/08/22
Unusually active option classes on open November 8th
10/26/22
Unusually active option classes on open October 26th
General news
Energy Action: » 06:40
12/06/22
12/06
06:40
12/06/22
06:40
$ECON

Economic Data

/

+

Energy Action: Oil prices…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

06/22/22
President Biden calls on Congress to suspend federal gas tax
$ECON Economic Data
/

+

$ECON Economic Data
/

+

06/14/22
Ackman says 100 point hike tomorrow 'would be better' than 75
$ECON Economic Data
/

+

11/04/22
Fed's Evans says smaller rate hikes make sense, Reuters reports
10/22/22
Fed set to raise rates by 0.75 point, discuss size of future hikes, WSJ says
10/10/22
JPMorgan CEO tells CNBC U.S. recession likely in 6 to 9 months
09/07/22
Fed Beige Book says price levels 'remained highly elevated'
$ECON Economic Data
/

+

11/30/22
What You Missed On Wall Street On Wednesday
11/28/22
What You Missed On Wall Street On Monday
11/28/22
What You Missed On Wall Street This Morning
11/02/22
What You Missed On Wall Street On Wednesday
Syndicate
HTG Molecular files automatic mixed securities shelf  06:39
12/06/22
12/06
06:39
12/06/22
06:39
HTGM

HTG Molecular

/

+

 
ShowHide Related Items >><<
HTGM HTG Molecular
/

+

10/26/22
HTG Molecular enters partnership with OmiCure for transcriptomic data
07/19/22
HTG Molecular to host KOL event addressing drug candidate attrition
07/18/22
HTG Molecular announces amendment to senior loan facility
07/06/22
HTG Molecular releases whitepaper for transcriptome-informed approach
HTGM HTG Molecular
/

+

07/22/22 Cantor Fitzgerald
HTG Molecular price target lowered to $3.50 from $15 at Cantor Fitzgerald
05/16/22 H.C. Wainwright
HTG Molecular price target lowered to $3 from $4 at H.C. Wainwright
03/30/22 H.C. Wainwright
HTG Molecular price target lowered to $4 from $9 at H.C. Wainwright
03/30/22 Craig-Hallum
HTG Molecular price target lowered to $3 from $8 at Craig-Hallum
Upgrade
Weichai Power upgraded to Buy from Hold at HSBC » 06:39
12/06/22
12/06
06:39
12/06/22
06:39
WEICY

Weichai Power

$10.55 /

+0.02 (+0.19%)

HSBC analyst Helen Fang…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WEICY Weichai Power
$10.55 /

+0.02 (+0.19%)

06:08 Today Daiwa
Weichai Power upgraded to Outperform from Hold at Daiwa
05/31/22 JPMorgan
Weichai Power upgraded to Overweight from Underweight at JPMorgan
Upgrade
Sinotruk upgraded to Buy from Hold at HSBC » 06:38
12/06/22
12/06
06:38
12/06/22
06:38
SHKLY

Sinotruk

$67.10 /

+ (+0.00%)

HSBC analyst Helen Fang…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SHKLY Sinotruk
$67.10 /

+ (+0.00%)

04/04/22 JPMorgan
Sinotruk downgraded to Underweight from Neutral at JPMorgan
02/27/22 Goldman Sachs
Sinotruk upgraded to Buy from Neutral at Goldman Sachs
Initiation
Carnival assumed with a Neutral at JPMorgan » 06:38
12/06/22
12/06
06:38
12/06/22
06:38
CCL

Carnival

$9.67 /

-0.33 (-3.30%)

JPMorgan analyst Daniel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CCL Carnival
$9.67 /

-0.33 (-3.30%)

12/01/22
Holland America Line reports 'record' Black Friday bookings in the U.S.
11/29/22
Carnival says Cyber Monday bookings 50% above volume for Cyber Monday 2019
11/15/22
Carnival falls 11% to $9.95 after $1B convertible senior notes offering
11/03/22
Carnival says Arnold Donald to step down from board of directors
CCL Carnival
$9.67 /

-0.33 (-3.30%)

11/17/22 Credit Suisse
Norwegian Cruise downgraded to Underperform from Outperform at Credit Suisse
11/14/22 UBS
Carnival price target raised to $16 from $8 at UBS
10/27/22 Tigress Financial
Tigress Financial sees 45% 12-month upside in Carnival shares
10/12/22 UBS
Carnival price target lowered to $8 from $11 at UBS
CCL Carnival
$9.67 /

-0.33 (-3.30%)

09/30/22
Carnival sees net loss, breakeven to slightly negative adjusted EBITDA in Q4
09/30/22
Carnival reports Q3 EPS (65c), consensus (13c)
09/29/22
Notable companies reporting before tomorrow's open
09/29/22
Notable companies reporting before tomorrow's open
  • 21
    Jul
CCL Carnival
$9.67 /

-0.33 (-3.30%)

10/24/22
Carnival's Costa Cruises canceling Asia departures, Bloomberg reports
07/02/22
Not the time to bottom-fish cruise operator stocks, Barron's says
06/13/22
Carnival CEO tells Bloomberg company is 'recession resilient'
CCL Carnival
$9.67 /

-0.33 (-3.30%)

12/02/22
Sell these stocks now, proven algorithm says
11/19/22
Buy/Sell: Wall Street's top 10 stock calls this week
11/16/22
Fly Intel: Pre-market Movers
11/15/22
Fly Intel: After-Hours Movers
CCL Carnival
$9.67 /

-0.33 (-3.30%)

12/05/22
Early notable gainers among liquid option names on December 5th
12/02/22
Carnival call volume above normal and directionally bullish
12/01/22
Carnival call volume above normal and directionally bullish
11/25/22
Unusually active option classes on open November 25th
Hot Stocks
Sage Therapeutics, Biogen complete NDA to FDA for zuranolone » 06:37
12/06/22
12/06
06:37
12/06/22
06:37
SAGE

Sage Therapeutics

$43.54 /

-0.05 (-0.11%)

, BIIB

Biogen

$292.64 /

-6.35 (-2.12%)

Sage Therapeutics (SAGE)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SAGE Sage Therapeutics
$43.54 /

-0.05 (-0.11%)

11/08/22
Sage sees cash and equivalents of $1.3B at end of FY22
11/01/22
Sage Therapeutics appoints Laura Gault, M.D. as Chief Medical Officer
10/17/22
Sage Therapeutics and Biogen present Phase 3 zuranolone results in depression
09/19/22
Sage Therapeutics, Biogen present analyses on efficacy, safety of zuranolone
BIIB Biogen
$292.64 /

-6.35 (-2.12%)

12/05/22
Biogen announces EMA accepted tofersen MAA to treat rare form of ALS
11/29/22
Eisai and Biogen present full results for Lecanemab phase 3 study in AD
11/10/22
Biogen names Viehbacher president, CEO
10/17/22
Biogen announces FDA's 3-month expansion of review filing for NDA for tofersen
SAGE Sage Therapeutics
$43.54 /

-0.05 (-0.11%)

11/09/22 H.C. Wainwright
Sage Therapeutics price target lowered to $50 from $55 at H.C. Wainwright
11/01/22 Loop Capital
Sage Therapeutics initiated with a Hold at Loop Capital
08/03/22 Citi
Sage Therapeutics price target lowered to $40 from $41 at Citi
08/02/22 Stifel
Sage Therapeutics price target lowered to $56 from $58 at Stifel
BIIB Biogen
$292.64 /

-6.35 (-2.12%)

12/02/22 JonesTrading
Anavex price target raised to $80 from $40 at JonesTrading
12/01/22 Atlantic Equities
Biogen price target raised to $295 from $220 at Atlantic Equities
11/30/22 Mizuho
Mizuho says Biogen not mentioned in 90 minute lecanemab presentation
11/30/22 Jefferies
Biogen price target raised to $350 from $325 at Jefferies
SAGE Sage Therapeutics
$43.54 /

-0.05 (-0.11%)

11/08/22
Sage Therapeutics reports Q3 EPS ($2.31), consensus ($2.21)
08/02/22
Sage Therapeutics reports Q2 EPS ($2.13), consensus ($2.15)
BIIB Biogen
$292.64 /

-6.35 (-2.12%)

10/25/22
Biogen raises FY22 EPS view to $16.50-$17.15, consensus $16.49
10/25/22
Biogen reports Q3 adjusted EPS $4.77, consensus $4.15
10/24/22
Notable companies reporting before tomorrow's open
10/24/22
Notable companies reporting before tomorrow's open
BIIB Biogen
$292.64 /

-6.35 (-2.12%)

11/28/22
Second death linked to Eisai's lecanemab Alzheimer's drug, Science says
11/07/22
Biogen weighing new CEO options after talks with J&J exec hit impasse, STAT says
10/28/22
Investigator in Alzheimer's trial linked lecanemab to patient death, STAT says
10/07/22
Former J&J exec emerges as top candidate to become Biogen CEO, Statnews reports
BIIB Biogen
$292.64 /

-6.35 (-2.12%)

11/30/22
Fly Intel: Pre-market Movers
11/28/22
Fly Intel: Pre-market Movers
11/14/22
What You Missed On Wall Street On Monday
11/14/22
What You Missed On Wall Street This Morning
12/07/22
Biopharma Spotlight: Global Large Cap Virtual Conference
08:00 Today
Biogen - BIIB
08:00 Today
Sage Therapeutics - SAGE
12/15/22
Sage Therapeutics
BIIB Biogen
$292.64 /

-6.35 (-2.12%)

11/30/22
Early notable gainers among liquid option names on November 30th
11/14/22
Early notable gainers among liquid option names on November 14th
10/13/22
Early notable gainers among liquid option names on October 13th
09/29/22
Unusually active option classes on open September 29th
Hot Stocks
Whitestone REIT provides update on disposition activities » 06:37
12/06/22
12/06
06:37
12/06/22
06:37
WSR

Whitestone REIT

$9.57 /

-0.245 (-2.50%)

Whitestone REIT has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WSR Whitestone REIT
$9.57 /

-0.245 (-2.50%)

11/10/22
Whitestone REIT releases 2022 ESG report
WSR Whitestone REIT
$9.57 /

-0.245 (-2.50%)

12/05/22 Truist
Whitestone REIT price target raised to $10 from $9 at Truist
12/02/22 Truist
Whitestone REIT price target raised to $10 from $9 at Truist
08/30/22 Truist
Truist starts Whitestone REIT at Hold, sees challenging 2023 setup
08/30/22 Truist
Whitestone REIT initiated with a Hold at Truist
Hot Stocks
Editas Medicine's EDIT-301 shows safety and efficacy in sickle cell disease » 06:36
12/06/22
12/06
06:36
12/06/22
06:36
EDIT

Editas Medicine

$9.83 /

-0.425 (-4.15%)

Editas Medicine announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EDIT Editas Medicine
$9.83 /

-0.425 (-4.15%)

11/17/22
Editas sinks 17% to $10.11 after pausing BRILLIANCE study enrollment
11/17/22
Editas Medicine announces clinical data from Phase 1/2 BRILLIANCE trial
10/18/22
Editas Medicine rises after report of talks to sell preclinical oncology assets
10/13/22
Editas Medicine presents preclinical data on EDIT-103 for RHO-adRP
EDIT Editas Medicine
$9.83 /

-0.425 (-4.15%)

12/05/22 Credit Suisse
Editas Medicine assumed with a Neutral at Credit Suisse
11/18/22 Morgan Stanley
Editas Medicine price target lowered to $8 from $10 at Morgan Stanley
11/18/22 BofA
Editas' EDIT-101 setback 'not the end of the story,' says BofA
11/18/22 RBC Capital
Editas Medicine price target lowered to $14 from $32 at RBC Capital
EDIT Editas Medicine
$9.83 /

-0.425 (-4.15%)

11/02/22
Editas Medicine reports Q3 EPS (81c), consensus (86c)
08/03/22
Editas Medicine reports Q2 EPS (78c), consensus (82c)
EDIT Editas Medicine
$9.83 /

-0.425 (-4.15%)

10/18/22
Editas in talks to sell preclinical oncology assets, Endpoints News says
07/25/22
Researchers warn CRISPR gene editing may trigger cancer, Jerusalem Post says
EDIT Editas Medicine
$9.83 /

-0.425 (-4.15%)

11/21/22
Biotech Alert: Searches spiking for these stocks today
11/18/22
What You Missed On Wall Street On Friday
11/18/22
What You Missed On Wall Street This Morning
11/18/22
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
08:00 Today
Editas Medicine - EDIT
Hot Stocks
X-energy to go public via merger with Ares Acquisition » 06:36
12/06/22
12/06
06:36
12/06/22
06:36
AAC

Ares Acquisition

$10.04 /

-0.005 (-0.05%)

X Energy Reactor Company,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Downgrade
Royal Caribbean assumed with Underweight from Overweight at JPMorgan » 06:35
12/06/22
12/06
06:35
12/06/22
06:35
RCL

Royal Caribbean

$59.44 /

-1.07 (-1.77%)

, NCLH

Norwegian Cruise Line

$16.22 /

-0.325 (-1.96%)

JPMorgan analyst Daniel…

JPMorgan analyst Daniel Adam double downgraded Royal Caribbean (RCL) to Underweight from Overweight with a price target of $47, down from $106, after assuming coverage of the name. Despite roughly $10B of capital raises so far this year and free cash flow generation that should cover most, but not all, of its future commitments, Royal could face a $400M funding shortfall by the end of next year, Adam tells investors in a research note. Additionally, in order to achieve its investment grade credit rating target by 2025, Royal likely needs to raise an additional $3.5B, via either equity or asset sales, says the analyst. He says that at current levels, a $3.5B equity deal would be 20% dilutive to shareholders. Adam prefers Norwegian Cruise Line (NCLH) to Royal Caribbean, as he sees near-term funding requirements for the former as "less onerous."

ShowHide Related Items >><<
RCL Royal Caribbean
$59.44 /

-1.07 (-1.77%)

12/01/22
Royal Caribbean International says bookings records set for third time in 2022
11/10/22
Royal Caribbean opens $125M cruise terminal in Galveston with Allure of the Seas
11/03/22
Royal Caribbean sees returning to historical load factors in early summer 2023
11/03/22
Royal Caribbean: Trifecta program to increase adjusted EPS to double digits
NCLH Norwegian Cruise Line
$16.22 /

-0.325 (-1.96%)

11/28/22
OneSpaWorld enters seven-year contract with Norwegian Cruise Line
11/16/22
Norwegian Cruise Line CEO sells $1.06M in common stock
11/08/22
Norwegian Cruise Line expects to report net loss for Q4
11/08/22
Norwegian Cruise Line on track to generate positive adjusted FCF in Q4
RCL Royal Caribbean
$59.44 /

-1.07 (-1.77%)

11/22/22 Truist
Royal Caribbean price target raised to $62 from $58 at Truist
11/17/22 Credit Suisse
Norwegian Cruise downgraded to Underperform from Outperform at Credit Suisse
11/14/22 UBS
Royal Caribbean price target raised to $76 from $56 at UBS
10/21/22 Tigress Financial
Royal Caribbean shares have upside to $80, says Tigress Financial
NCLH Norwegian Cruise Line
$16.22 /

-0.325 (-1.96%)

11/22/22 Truist
Norwegian Cruise Line price target raised to $21 from $19 at Truist
11/17/22 Credit Suisse
Norwegian Cruise downgraded to Underperform from Outperform at Credit Suisse
11/14/22 UBS
Norwegian Cruise Line price target raised to $24 from $15 at UBS
11/11/22 Deutsche Bank
Norwegian Cruise Line price target lowered to $14 from $16 at Deutsche Bank
RCL Royal Caribbean
$59.44 /

-1.07 (-1.77%)

11/03/22
Royal Caribbean sees Q4 adjusted EPS ($1.50)-($1.30), consensus (67c)
11/03/22
Royal Caribbean reports Q3 adjusted EPS 26c, consensus 19c
11/02/22
Notable companies reporting before tomorrow's open
11/02/22
Notable companies reporting before tomorrow's open
NCLH Norwegian Cruise Line
$16.22 /

-0.325 (-1.96%)

11/08/22
Norwegian Cruise Line sees Q4 reveue $1.4B-$1.5B, consensus $1.46B
11/08/22
Norwegian Cruise Line reports Q3 adjusted EPS (64c), consensus (70c)
08/09/22
Norwegian Cruise Line sees Q3 revenue $1.5B-$1.6B, consensus $1.88B
08/09/22
Norwegian Cruise Line reports Q2 adjusted EPS ($1.14), consensus (86c)
RCL Royal Caribbean
$59.44 /

-1.07 (-1.77%)

08/17/22
Royal Caribbean seeks approval to sail again in Hong Kong, SCMP reports
08/13/22
Royal Caribbean among companies at risk of liquidity squeeze, Barron's says
07/02/22
Not the time to bottom-fish cruise operator stocks, Barron's says
NCLH Norwegian Cruise Line
$16.22 /

-0.325 (-1.96%)

07/02/22
Not the time to bottom-fish cruise operator stocks, Barron's says
RCL Royal Caribbean
$59.44 /

-1.07 (-1.77%)

12/02/22
Sell these stocks now, proven algorithm says
11/19/22
Buy/Sell: Wall Street's top 10 stock calls this week
11/18/22
Sell these stocks now, proven algorithm says
11/17/22
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
NCLH Norwegian Cruise Line
$16.22 /

-0.325 (-1.96%)

11/19/22
Buy/Sell: Wall Street's top 10 stock calls this week
11/17/22
What You Missed On Wall Street On Thursday
11/17/22
What You Missed On Wall Street This Morning
11/17/22
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
12/12/22
Norwegian Cruise Line
12/13/22
Norwegian Cruise Line
RCL Royal Caribbean
$59.44 /

-1.07 (-1.77%)

11/03/22
Unusually active option classes on open November 3rd
10/18/22
Early notable gainers among liquid option names on October 18th
10/10/22
Royal Caribbean put volume heavy and directionally bearish
10/10/22
Unusually active option classes on open October 10th
NCLH Norwegian Cruise Line
$16.22 /

-0.325 (-1.96%)

12/05/22
Early notable gainers among liquid option names on December 5th
11/08/22
Early notable gainers among liquid option names on November 8th
11/08/22
Unusually active option classes on open November 8th
10/26/22
Unusually active option classes on open October 26th
Earnings
KVH Industries reports Q3 non-GAAP EPS 7c, consensus 1c » 06:33
12/06/22
12/06
06:33
12/06/22
06:33
KVHI

KVH Industries

$10.61 /

-0.69 (-6.11%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KVHI KVH Industries
$10.61 /

-0.69 (-6.11%)

11/21/22
KVH Industries receives noncompliance notification from Nasdaq
10/25/22
U.S. Coast Guard selects KVH Industries for five-year connectivity contract
08/19/22
KVH Industries adopts limited duration stockholder rights plan
07/07/22
KVH Industries introduces KVH ONE hybrid network
KVHI KVH Industries
$10.61 /

-0.69 (-6.11%)

08/09/22
KVH Industries reports Q2 EPS 4c, consensus (8c)
09:00 Today
KVH Industries - KVHI
Hot Stocks
Karuna Therapeutics names Bill Meury as CEO, succeeding Steve Paul, M.D. » 06:32
12/06/22
12/06
06:32
12/06/22
06:32
KRTX

Karuna Therapeutics

$227.06 /

-9.145 (-3.87%)

Karuna Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KRTX Karuna Therapeutics
$227.06 /

-9.145 (-3.87%)

10/06/22
Karuna Therapeutics to present data from Phase 3 trial of KarXT
10/04/22
Karuna Therapeutics CFO sells $3.44M in common stock
08/08/22
Zai Lab partner Karuna announces results from Phase 3 EMERGENT-2 trial
08/08/22
Karuna Therapeutics says Phase 3 EMERGENT-2 trial met primary endpoint
KRTX Karuna Therapeutics
$227.06 /

-9.145 (-3.87%)

11/01/22 Loop Capital
Karuna Therapeutics initiated with a Buy at Loop Capital
09/29/22 RBC Capital
Karuna Therapeutics price target raised to $293 from $292 at RBC Capital
09/26/22 Wells Fargo
Cerevel Therapeutics initiated with an Overweight at Wells Fargo
09/13/22 Stifel
Karuna Therapeutics price target raised to $295 from $260 at Stifel
KRTX Karuna Therapeutics
$227.06 /

-9.145 (-3.87%)

11/03/22
Karuna Therapeutics reports Q3 EPS ($2.38), consensus ($2.13)
08/08/22
Karuna Therapeutics reports Q2 EPS ($2.17), consensus ($2.09)
  • 10
    Aug
KRTX Karuna Therapeutics
$227.06 /

-9.145 (-3.87%)

11/01/22
What You Missed On Wall Street On Tuesday
11/01/22
What You Missed On Wall Street This Morning
11/01/22
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
08/08/22
What You Missed On Wall Street On Monday
Periodicals
NLRB says Apple violated law with anti-union tactics, Bloomberg reports » 06:29
12/06/22
12/06
06:29
12/06/22
06:29
AAPL

Apple

$146.61 /

-1.21 (-0.82%)

The Atlanta regional…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AAPL Apple
$146.61 /

-1.21 (-0.82%)

12/04/22
Fly Intel: Top five weekend stock stories
12/02/22
Coinbase says Apple blocked last app release on NFTs
11/30/22
Musk says Apple CEO never considered removing Twitter from App Store
11/28/22
Musk says Apple 'threatened to withhold Twitter' from App Store
AAPL Apple
$146.61 /

-1.21 (-0.82%)

12/05/22 Wedbush
Apple shift out of China will not be easy, says Wedbush
12/02/22 Morgan Stanley
Morgan Stanley sees December quarter App Store forecast as 'conservative'
12/01/22 Piper Sandler
Apple estimates lowered on shutdowns in Zhengzhou at Piper Sandler
11/30/22 Wedbush
China lockdown ends in iPhone city, heavy lifting ahead for Apple, says Wedbush
AAPL Apple
$146.61 /

-1.21 (-0.82%)

10/27/22
Apple reports Q4 EPS $1.29, consensus $1.17
10/27/22
Notable companies reporting after market close
07/28/22
Apple reports Q3 EPS $1.20, consensus $1.16
07/28/22
Notable companies reporting after market close
AAPL Apple
$146.61 /

-1.21 (-0.82%)

12/05/22
Apple store workers in St. Louis push back on union efforts, Bloomberg says
12/05/22
MercadoLibre files complaint against Apple in Brazil, Mexico, Reuters reports
12/05/22
MercadoLibre files complaint against Apple in Brazil and Mexico, Bloomberg says
12/05/22
Apple held talks with India to move some iPad production, CNBC reports
AAPL Apple
$146.61 /

-1.21 (-0.82%)

12/05/22
What You Missed On Wall Street On Monday
12/05/22
What You Missed On Wall Street This Morning
12/02/22
Here's What You Missed in Crypto This Week
11/30/22
#SocialStocks: Twitter and Apple spar over advertising, censorship
AAPL Apple
$146.61 /

-1.21 (-0.82%)

12/05/22
Early notable gainers among liquid option names on December 5th
12/05/22
Notable open interest changes for December 5th
12/02/22
Notable open interest changes for December 2nd
11/30/22
Notable open interest changes for November 30th
Downgrade
Salisbury Bancorp downgraded to Neutral from Buy at Janney Montgomery Scott » 06:29
12/06/22
12/06
06:29
12/06/22
06:29
SAL

Salisbury Bancorp

$31.23 /

+0.14 (+0.45%)

Janney Montgomery Scott…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SAL Salisbury Bancorp
$31.23 /

+0.14 (+0.45%)

12/05/22
Salisbury Bancorp trading resumes
12/05/22
NBT Bancorp, Salisbury Bancorp announces agreement to merge
12/05/22
Salisbury Bancorp trading halted, news pending
07/01/22
Salisbury Bancorp completes two-for-one forward stock split
SAL Salisbury Bancorp
$31.23 /

+0.14 (+0.45%)

12/05/22
What You Missed On Wall Street On Monday
12/05/22
What You Missed On Wall Street This Morning
Hot Stocks
F-star Therapeutics presents clinical data on antitumor activity of FS222 » 06:29
12/06/22
12/06
06:29
12/06/22
06:29
FSTX

F-star Therapeutics

$5.56 /

-0.03 (-0.54%)

F-star Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FSTX F-star Therapeutics
$5.56 /

-0.03 (-0.54%)

11/07/22
F-star announces publication of Phase 1 dose-escalation trial of FS118
07/20/22
F-star Therapeutics announces license agreement with Takeda
06/23/22
F star Therapeutics trading resumes
06/23/22
invoX Pharma to acquire F-star Therapeutics for $7.12 per share
FSTX F-star Therapeutics
$5.56 /

-0.03 (-0.54%)

07/15/22 H.C. Wainwright
F-star Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
06/23/22 SVB Leerink
F-star Therapeutics downgraded to Market Perform from Outperform at SVB Leerink
06/23/22 Laidlaw
F-star Therapeutics downgraded to Hold from Buy at Laidlaw
06/23/22 Ladenburg
F-star Therapeutics downgraded to Neutral from Buy at Ladenburg
FSTX F-star Therapeutics
$5.56 /

-0.03 (-0.54%)

08/11/22
F-star Therapeutics reports Q2 EPS (88c) vs. (91c) last year
Recommendations
DocuSign price target lowered to $59 from $76 at Citi » 06:26
12/06/22
12/06
06:26
12/06/22
06:26
DOCU

DocuSign

$42.44 /

-4.135 (-8.88%)

Citi analyst Tyler Radke…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DOCU DocuSign
$42.44 /

-4.135 (-8.88%)

10/04/22
Cathie Wood says moved out of DocuSign, did not understand competition
09/28/22
DocuSign announces restructuring plan, to reduce workforce by 9%
09/22/22
DocuSign names Allan Thygesen as new CEO
09/08/22
DocuSign jumps 17% to $67.90 after Q2 earnings beat and guidance
DOCU DocuSign
$42.44 /

-4.135 (-8.88%)

12/05/22 UBS
DocuSign price target lowered to $52 from $65 at UBS
12/05/22 Baird
DocuSign price target lowered to $50 from $70 at Baird
11/30/22 Jefferies
DocuSign initiated with a Hold at Jefferies
10/12/22 Wedbush
Wedbush upgrades DocuSign to Neutral with $55 price target
DOCU DocuSign
$42.44 /

-4.135 (-8.88%)

09/08/22
DocuSign sees FY23 revenue $2.47B-$2.48B, consensus $2.47B
09/08/22
DocuSign sees Q3 revenue $624M-$628M, consensus $625.05M
09/08/22
DocuSign reports Q2 non-GAAP EPS 44c, consensus 42c
09/08/22
Notable companies reporting after market close
DOCU DocuSign
$42.44 /

-4.135 (-8.88%)

07/01/22
DocuSign challenges could lead to activist or suitor, The Deal says
DOCU DocuSign
$42.44 /

-4.135 (-8.88%)

11/30/22
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
10/12/22
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
10/03/22
What You Missed On Wall Street On Monday
10/03/22
What You Missed On Wall Street This Morning
12/08/22
DocuSign - DOCU
DOCU DocuSign
$42.44 /

-4.135 (-8.88%)

12/05/22
DocuSign put volume heavy and directionally bearish
09/08/22
DocuSign options imply 13.1% move in share price post-earnings
09/01/22
DocuSign put volume heavy and directionally bearish
08/19/22
DocuSign put volume heavy and directionally bearish
Hot Stocks
Cenovus Energy reports 2023 budget and production guidance » 06:25
12/06/22
12/06
06:25
12/06/22
06:25
CVE

Cenovus Energy

$19.17 /

-0.78 (-3.91%)

Cenovus Energy announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CVE Cenovus Energy
$19.17 /

-0.78 (-3.91%)

11/14/22
Third Point buys TJX, exits Cenovus Energy in Q3
11/07/22
Cenovus Energy renews share buyback program
09/29/22
Cenovus to help advance sustainable energy opportunities for First Nations
08/26/22
Cenovus Energy announces tender offer for certain outstanding series of notes
CVE Cenovus Energy
$19.17 /

-0.78 (-3.91%)

11/21/22 Credit Suisse
Cenovus Energy price target lowered to C$35 from C$37 at Credit Suisse
11/21/22 Goldman Sachs
Cenovus Energy downgraded to Neutral from Buy at Goldman Sachs
11/03/22 Raymond James
Cenovus Energy price target raised to C$32 from C$30 at Raymond James
11/03/22 RBC Capital
Cenovus Energy price target raised to C$32 from C$31 at RBC Capital
CVE Cenovus Energy
$19.17 /

-0.78 (-3.91%)

11/02/22
Cenovus Energy reports Q3 total revenue $20.01B, consensus $11.41B
07/28/22
Cenovus Energy reports Q2 EPS $1.19, consensus 82c
CVE Cenovus Energy
$19.17 /

-0.78 (-3.91%)

09/28/22
BP lays off most contractors at Toledo plant after fire, Reuters says
09/21/22
BP says two employees died after fire at refinery in Ohio, WSJ reports
CVE Cenovus Energy
$19.17 /

-0.78 (-3.91%)

10/06/22
Cenovus Energy call volume above normal and directionally bullish
09/26/22
Cenovus Energy call volume above normal and directionally bullish
09/23/22
Cenovus Energy put volume heavy and directionally bearish
09/12/22
Cenovus Energy put volume heavy and directionally bearish
Hot Stocks
Standard Lithium signs key agreement for access to commercial lithium plant » 06:24
12/06/22
12/06
06:24
12/06/22
06:24
SLI

Standard Lithium

$3.88 /

-0.295 (-7.07%)

Standard Lithium is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SLI Standard Lithium
$3.88 /

-0.295 (-7.07%)

05:40 Today
Standard Lithium secures access to the proposed commercial lithium plant site
11/10/22
Standard Lithium reports $124M cash on hand as of September 30
11/01/22
Standard Lithium issued two U.S. patents for lithium recovery processes
11/01/22
Standard Lithium announces notices of allowance for two U.S. patent applications
SLI Standard Lithium
$3.88 /

-0.295 (-7.07%)

03/15/22 Stifel
Standard Lithium resumed with a Buy at Stifel
Recommendations
PVH Corp. price target raised to $72 from $60 at Barclays » 06:22
12/06/22
12/06
06:22
12/06/22
06:22
PVH

PVH Corp.

$71.15 /

-1.79 (-2.45%)

Barclays analyst Adrienne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PVH PVH Corp.
$71.15 /

-1.79 (-2.45%)

12/01/22
PVH Corp. rises 10.2%
12/01/22
PVH Corp. rises 10.5%
11/30/22
PVH Corp. jumps 9% to $73.38 after Q3 earnings beat, guidance raise
11/30/22
PVH Corp. extends licenses with G-III Apparel
PVH PVH Corp.
$71.15 /

-1.79 (-2.45%)

12/05/22 Deutsche Bank
PVH Corp. price target raised to $77 from $72 at Deutsche Bank
12/05/22 Citi
PVH Corp. price target raised to $74 from $60 at Citi
12/02/22 UBS
PVH Corp. price target raised to $100 from $84 at UBS
12/02/22 Morgan Stanley
PVH Corp. assumed with an Equal Weight at Morgan Stanley
PVH PVH Corp.
$71.15 /

-1.79 (-2.45%)

11/30/22
PVH Corp. raises FY22 EPS view to $8.25 from $8, consensus $7.89
11/30/22
PVH Corp. sees Q4 adjusted EPS $1.65, consensus $1.70
11/30/22
PVH Corp. reports Q3 adjusted EPS $2.60, consensus $2.15
11/30/22
Notable companies reporting after market close
PVH PVH Corp.
$71.15 /

-1.79 (-2.45%)

12/01/22
What You Missed On Wall Street On Thursday
12/01/22
What You Missed On Wall Street This Morning
12/01/22
Fly Intel: Pre-market Movers
11/30/22
Fly Intel: After-Hours Movers
PVH PVH Corp.
$71.15 /

-1.79 (-2.45%)

09/19/22
Early notable gainers among liquid option names on September 19th
08/30/22
PVH Corp. options imply 5.2% move in share price post-earnings
07/19/22
Early notable gainers among liquid option names on July 19th

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.